Lobbying registration dated 2026-02-10
Registrant: Dimitris Polygenis
Client: McKesson Canada
Targeted institutions:
Intergovernmental Affairs Secretariat (IGA)
Environment and Climate Change Canada (ECCC)
Justice Canada (JC)
Employment and Social Development Canada (ESDC)
Public Safety Canada (PS)
Finance Canada (FIN)
Treasury Board Of Canada Secretariat (TBS)
Public Services and Procurement Canada (PSPC)
Prime Minister's Office (PMO)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Indigenous Services Canada (ISC)
Competition Bureau Canada (COBU)
Global Affairs Canada (GAC)
Public Health Agency of Canada (PHAC)
Patented Medicine Prices Review Board (PMPRB)
Privy Council Office (PCO)
Health Canada (HC)
Government funding received:
Lobbying activity details:
How AI, automation, and healthcare data interoperability can support patient care throughout the healthcare system, particularly in the pharmacy and pharmaceutical distribution sectors
Medical cannabis policy impacts on pharmacy and the wholesale industry
Approaches towards National Pharmacare policy
Development of screening programs in First Nations communities
Policies and programs aimed at red tape reduction to reduce regulatory burdens and timelines in the pharmaceutical distribution and associated sectors
Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs
Health Canada, with respect to the role of wholesalers in the management of drug shortages
Health Canada, with respect to pandemic planning, particularly federal/provincial/territorial storage and distribution of pharmaceuticals
Approaches to mitigating the impact of COVID-19 on the pharmaceutical distribution, pharmacy, primary care, and other healthcare sectors
Offer recommendations on the Patented Medicines Pricing Review Board excessive pricing policy guidelines and implementation approaches to support drug supply stability and system sustainability
Health Canada, with respect to the regulation and funding of wholesale distribution of pharmaceuticals and regulation of pharmacy activities